MarketInOut Stock Screener Log In | Sign Up

Bolt Biotherapeutics Inc

NASDAQ • Healthcare • Biotechnology • Quote as of 10/30/2026
Bolt Biotherapeutics Inc stock price and volume chart

Company Profile

IndustryBiotechnology
SectorHealthcare
ExchangeNASDAQ
Market Capitalization15.53 mln
Float1.64 mln
Earnings Date11/05/2026

Piotroski F-Score

4 / 9
Borderline

Beneish M-Score

-3.45
Reliable

Relative Strength

100 / 100
Top performer

Debt / Equity

1.71
High leverage

Pre-Tax Margin

-611%
Severely loss-making

ROE

-111
Deeply negative

Business Description

Bolt Biotherapeutics is a California-based company working to develop new cancer treatments that harness the body's immune system. Its pipeline includes several experimental therapies targeting different cancer types, such as stomach, lung, and pancreatic cancers, along with melanoma. The company also maintains two proprietary drug development platforms that it uses internally and offers to outside pharmaceutical partners.

Key Fundamentals

EPS-16.51
ROE-111
RPS2.78
ROIC-83.53
ROA-49.32
EBITDA, mln-27.82
EV / EBITDA-0.55
EV / EBIT-0.53
Revenue, mln4.70
EV / Revenue3.23

Quote Details

Last 6.59
Change 0.23 (3.62%)
Open 6.28
Volume 249,840
Turnover 1,646,446
Average Volume 670,766

Financial Ratios

Pre-Tax Profit Margin-611
Leverage Ratio3.19
Current Ratio2.61
Price / Book0.97
Price / Tangible Book0.97
Debt / Equity1.71
Price / Sales2.45

Financial Strength

Altman Z-Score-18.1
Piotroski F-Score 4 / 9
Beneish M-Score-3.45
Short Ratio0.45
Short % of Float0.82

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week 5.1% 88 / 100   
1 Month 87.75% 100 / 100   
2 Months 65.99% 98 / 100   
6 Months 30.24% 92 / 100   
1 Year 12.46% 72 / 100   



Disclaimer - Privacy Policy - Terms of Service - Cookies - FAQ - Affiliates - Blog